Mesalamine 4gm Kit (4 Kits)
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all provided information carefully. This medication is designed for rectal use only and should not be taken by mouth. You may be prescribed both an oral tablet or capsule and a rectal product to take at the same time.
Continue using this medication as directed by your doctor or healthcare provider, even if you start feeling well. It is recommended to use this medication at bedtime. Before using, make sure you understand the proper administration technique. If you have any questions or concerns, consult your doctor or pharmacist.
Administration Instructions
Shake the suspension well before use.
Retain the suspension in your rectum for as long as possible.
Note that the enema may darken slightly over time after opening the foil pouch. It can still be used if the color change is minor. However, do not use it if it turns dark brown. If you are unsure about the enema's usability, consult your doctor or pharmacist.
Storage and Disposal
Store this medication at room temperature.
Keep the rectal suspension in its foil packaging until ready to use. Do not refrigerate.
Protect the rectal suspension from heat sources.
Missed Dose
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Administer the enema at bedtime, if possible, to allow the medication to remain in the colon for several hours (ideally 8 hours) for maximum effectiveness.
- Lie on your left side with your lower leg extended and your upper leg bent forward for easier administration and retention.
- Try to retain the enema for as long as possible, preferably overnight, to allow the medication to work.
- Follow your doctor's instructions regarding diet and other lifestyle modifications for ulcerative colitis.
- Do not stop using this medication without consulting your doctor, even if you feel better, as symptoms may return.
Available Forms & Alternatives
Available Strengths:
- Mesalamine Rectal Susp 28x60ml
- Mesalamine Rectal Susp 7x60ml
- Mesalamine 4gm Kit( 7 X 60ml)
- Mesalamine 4gm Kit (4 Kits)
- Mesalamine 800mg DR Tablets
- Mesalamine 400mg DR Capsules
- Mesalamine 1000mg Suppositories
- Mesalamine 1.2gm Tablets
- Mesalamine 0.375gm Capsules
- Mesalamine 0.375gm ER Capsules
- Mesalamine 500mg ER Capsules
- Mesalamine 0.375gm Capsules
- Mesalamine Rectal Susp 7x60ml
- Mesalamine Rectal Susp 28x60ml
- Mesalamine 800mg DR Tablets
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to urinate or changes in urine output
+ Blood in the urine or significant weight gain
+ Back pain, abdominal pain, or blood in the urine (may indicate a kidney stone)
Chest pain or pressure, rapid or irregular heartbeat
Fever, chills, sore throat, unexplained bruising or bleeding, or feeling extremely tired or weak
Rectal bleeding or pain
Symptoms that may resemble ulcerative colitis, such as:
+ New or worsening stomach pain or cramps
+ Bloody stools
+ Fever
+ Headache
+ Itching
+ Rash
+ Red or pink eyes
+ General feeling of illness
Liver problems, which can be rare but potentially life-threatening, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Nausea or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Heart problems, which can be rare but potentially life-threatening, including:
+ Shortness of breath
+ Significant weight gain
+ Swelling in the arms or legs
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. However, if you notice any of the following side effects or if they bother you or persist, contact your doctor:
Constipation
Diarrhea
Stomach pain or upset stomach
Vomiting
Heartburn
Gas
Burping
Nose or throat irritation
Dizziness or headache
Back pain
Cough
* Rectal irritation
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe abdominal pain, cramping, or bloody diarrhea (may indicate acute intolerance syndrome or worsening colitis)
- Rash, hives, itching, swelling of the face/lips/tongue, difficulty breathing (signs of allergic reaction)
- Chest pain, shortness of breath, palpitations (signs of pericarditis/myocarditis)
- Unexplained fever, chills, sore throat, unusual bleeding or bruising (signs of blood problems)
- Yellowing of skin or eyes, dark urine, persistent nausea/vomiting, severe stomach pain (signs of liver problems)
- Swelling in your ankles or feet, decreased urination (signs of kidney problems)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Existing health conditions, including:
+ Kidney disease or liver disease
+ Stomach or bowel ulcers
+ Narrowing of the stomach valve or other types of stomach blockages
+ Blockages in the urinary tract (consult with your healthcare provider)
Other medications you are taking, including:
+ Prescription and over-the-counter (OTC) drugs
+ Natural products
+ Vitamins
Any health problems you have, as this is not an exhaustive list of potential interactions with this medication.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure you receive proper care and avoid potential interactions.
Monitoring Your Health
Follow your doctor's instructions for regular blood tests to monitor your health while taking this medication. Discuss any concerns or questions you have with your doctor.
Lab Tests and Results
This medication may affect the results of certain lab tests. Be sure to inform all your healthcare providers and lab personnel that you are taking this medication to ensure accurate test results.
Staying Hydrated
Drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.
Sulfite Allergy
If you have a sulfite allergy, consult with your doctor before taking this medication, as some products may contain sulfites.
Urine Color Change
While taking this medication, your urine may turn reddish-brown when it comes into contact with surfaces or water that have been treated with bleach (e.g., toilet water). If you notice this color change, observe your urine flow. Only contact your doctor if your urine appears reddish-brown before it comes into contact with any surfaces or water that may have been treated with bleach.
Sun Protection
You may be more susceptible to sunburn while taking this medication. To protect yourself, avoid sun exposure, sunlamps, and tanning beds. Use sunscreen and wear protective clothing and eyewear when spending time outdoors.
Special Considerations for Older Adults
If you are 65 or older, use this medication with caution, as you may be more prone to side effects.
Use in Children
Not all products are suitable for use in children. Consult with your doctor before giving this medication to a child. Additionally, do not give this medication to children or teenagers who have or are recovering from flu symptoms, chickenpox, or other viral infections, as it may increase the risk of Reye's syndrome, a condition that can cause serious brain and liver problems.
Staining and Discoloration
This medication may stain fabric, flooring, painted surfaces, marble, granite, vinyl, and enamel.
Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the potential benefits and risks of taking this medication to you and your baby.
Overdose Information
Overdose Symptoms:
- Although systemic absorption is low with rectal administration, symptoms of overdose from oral mesalamine include: nausea, vomiting, abdominal pain, headache, dizziness, tinnitus, vertigo, confusion, hyperventilation, and in severe cases, metabolic acidosis, hyperthermia, and dehydration.
What to Do:
In case of suspected overdose, contact a poison control center immediately (e.g., 1-800-222-1222 in the US) or seek emergency medical attention. Management is supportive and symptomatic, focusing on maintaining fluid and electrolyte balance.
Drug Interactions
Major Interactions
- Azathioprine, Mercaptopurine (6-MP): Increased risk of myelosuppression due to inhibition of thiopurine methyltransferase (TPMT) by mesalamine. Monitor CBC closely.
- Nephrotoxic agents (e.g., NSAIDs, tacrolimus): Increased risk of renal adverse reactions. Monitor renal function.
Moderate Interactions
- Non-steroidal anti-inflammatory drugs (NSAIDs): May increase the risk of renal dysfunction when co-administered with mesalamine.
- Lactulose: May interfere with the release of mesalamine from some oral formulations (less relevant for rectal enema, but theoretical consideration).
Monitoring
Baseline Monitoring
Rationale: To establish baseline and identify pre-existing renal impairment, as mesalamine can cause renal toxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and identify pre-existing hepatic impairment, as mesalamine can cause hepatotoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and monitor for blood dyscrasias (e.g., agranulocytosis, aplastic anemia) which are rare but serious adverse effects.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Periodically (e.g., every 3-6 months or as clinically indicated), especially during the first year of treatment and with concomitant nephrotoxic drugs.
Target: Within normal limits or stable from baseline.
Action Threshold: Significant increase in creatinine, new onset proteinuria, or signs of renal dysfunction warrant investigation and potential discontinuation.
Frequency: Periodically (e.g., every 3-6 months or as clinically indicated).
Target: Within normal limits or stable from baseline.
Action Threshold: Significant elevation (e.g., >3x ULN) warrants investigation and potential discontinuation.
Frequency: Periodically (e.g., every 3-6 months or as clinically indicated), especially if co-administered with azathioprine or mercaptopurine.
Target: Within normal limits.
Action Threshold: Significant decrease in white blood cell count, platelet count, or hemoglobin warrants investigation and potential discontinuation.
Symptom Monitoring
- Worsening of ulcerative colitis symptoms (e.g., increased rectal bleeding, diarrhea, abdominal pain)
- Signs of hypersensitivity reaction (e.g., rash, fever, difficulty breathing, chest pain, pericarditis, myocarditis)
- Signs of renal dysfunction (e.g., decreased urine output, swelling, fatigue)
- Signs of hepatic dysfunction (e.g., jaundice, dark urine, persistent nausea/vomiting, abdominal pain)
- Signs of blood dyscrasias (e.g., unusual bruising/bleeding, persistent sore throat, fever, fatigue)
- Acute intolerance syndrome (cramping, acute abdominal pain, bloody diarrhea, fever, headache, rash)
Special Patient Groups
Pregnancy
Mesalamine is generally considered safe for use during pregnancy for the treatment of inflammatory bowel disease. Untreated or poorly controlled IBD can pose greater risks to pregnancy outcomes than mesalamine exposure. Category B indicates no evidence of risk in animal studies, but no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks:
Lactation
Mesalamine and its metabolite are excreted in breast milk in small amounts. Generally considered compatible with breastfeeding, but monitor the infant for signs of diarrhea.
Pediatric Use
Safety and effectiveness have not been established in pediatric patients. Use in children is generally off-label and requires careful consideration of risks vs. benefits by a specialist.
Geriatric Use
Use with caution in elderly patients, particularly those with pre-existing renal, hepatic, or cardiac impairment, due to increased susceptibility to adverse reactions. Monitor renal function closely.
Clinical Information
Clinical Pearls
- Ensure proper administration technique for the enema: lie on the left side, insert the applicator tip, squeeze the bottle, and retain the enema for at least 8 hours, ideally overnight.
- Patients should be advised that the enema solution may stain clothing and bedding.
- Mesalamine rectal enema is specifically for distal ulcerative colitis (proctitis, proctosigmoiditis, left-sided colitis) and may not be effective for more extensive disease.
- Regular monitoring of renal function is crucial, especially in patients with pre-existing renal disease or those on concomitant nephrotoxic medications.
- Acute intolerance syndrome (cramping, acute abdominal pain, bloody diarrhea, fever, headache, rash) can occur and may be difficult to distinguish from an exacerbation of ulcerative colitis. If suspected, discontinue therapy immediately.
Alternative Therapies
- Oral 5-ASAs (e.g., mesalamine tablets, sulfasalazine)
- Corticosteroids (e.g., hydrocortisone rectal foam/enema, oral prednisone)
- Immunomodulators (e.g., azathioprine, mercaptopurine, methotrexate)
- Biologic agents (e.g., infliximab, adalimumab, vedolizumab, ustekinumab)
- Janus Kinase (JAK) inhibitors (e.g., tofacitinib)